Vanguard Group Inc Nevro Corp Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Nevro Corp stock. As of the latest transaction made, Vanguard Group Inc holds 2,062,193 shares of NVRO stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,062,193

Previous 2,095,938 1.61%

Holding current value

$11.8 Million

Previous $11.7 Million 34.41%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$3.59 - $5.78 $121,144 - $195,046	-33,745 Reduced 1.61%	2,062,193 $7.67 Million
Q3 2024 Nov 13, 2024	SELL	$4.71 - $10.1 $1.24 Million - $2.67 Million	-264,250 Reduced 11.2%	2,095,938 $11.7 Million
Q2 2024 Aug 13, 2024	SELL	$7.96 - $13.59 $6.48 Million - $11.1 Million	-813,715 Reduced 25.64%	2,360,188 $19.9 Million
Q1 2024 May 10, 2024	SELL	$13.56 - $20.78 $12.1 Million - $18.6 Million	-893,368 Reduced 21.96%	3,173,903 $45.8 Million
Q4 2023 Feb 14, 2024	SELL	$14.18 - $22.31 $2.33 Million - $3.67 Million	-164,634 Reduced 3.89%	4,067,271 $87.5 Million
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $193,441 - $274,449	-10,617 Reduced 0.25%	4,231,905 $81.3 Million
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $2.78 Million - $4.83 Million	-122,865 Reduced 2.81%	4,242,522 $108 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $7.85 Million - $10.7 Million	260,037 Added 6.33%	4,365,387 $158 Million
Q4 2022 Feb 10, 2023	BUY	$36.43 - $49.4 $17.6 Million - $23.9 Million	484,265 Added 13.37%	4,105,350 $163 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2.45 Million - $3.2 Million	60,289 Added 1.69%	3,621,085 $169 Million
Q2 2022 Aug 12, 2022	BUY	$40.85 - $77.67 $12.6 Million - $24 Million	308,385 Added 9.48%	3,560,796 $156 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $4.03 Million - $6.19 Million	67,233 Added 2.11%	3,252,411 $235 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $4.38 Million - $6.55 Million	-54,036 Reduced 1.67%	3,185,178 $258 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $11.2 Million - $18.3 Million	-109,897 Reduced 3.28%	3,239,214 $377 Million
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $474 Million - $600 Million	3,349,111 New	3,349,111 $555 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

37.6M

Call Options Held

622K

Put Options Held

1.39M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $203M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nevro Corp Transaction History